130 related articles for article (PubMed ID: 12756053)
21. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Alvarez Castro AM; Seijo Ríos S; Molina Pérez E; Castroagudín JF; Varo Pérez E
Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
[TBL] [Abstract][Full Text] [Related]
22. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
[TBL] [Abstract][Full Text] [Related]
23. Langerhans' cell histiocytosis after living donor liver transplantation: report of a case.
Honda R; Ohno Y; Iwasaki T; Okudaira S; Okada M; Kamitamari A; Ohshima K; Moriuchi H; Kanematsu T
Liver Transpl; 2005 Nov; 11(11):1435-8. PubMed ID: 16237711
[TBL] [Abstract][Full Text] [Related]
24. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
Neuhaus P; Clavien PA; Kittur D; Salizzoni M; Rimola A; Abeywickrama K; Ortmann E; Chodoff L; Hall M; Korn A; Nashan B;
Liver Transpl; 2002 Feb; 8(2):132-42. PubMed ID: 11862589
[TBL] [Abstract][Full Text] [Related]
25. Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab.
Varo E; Lopez A; Castroagudin JF; Delgado M; Conde R; Ferrer E; Otero E; Tomé S; Bustamante M; Rivero C; Martinez J; Mariño A
Transplant Proc; 2002 Aug; 34(5):1533-4. PubMed ID: 12176471
[No Abstract] [Full Text] [Related]
26. Experience with basiliximab in pediatric liver graft recipients.
Ganschow R; Lyons M; Grabhorn E; Venzke A; Broering DC; Rogiers X; Hellwege HH; Burdelski M
Transplant Proc; 2001; 33(7-8):3606-7. PubMed ID: 11750532
[No Abstract] [Full Text] [Related]
27. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children.
Gras JM; Gerkens S; Beguin C; Janssen M; Smets F; Otte JB; Sokal E; Reding R
Liver Transpl; 2008 Apr; 14(4):469-77. PubMed ID: 18383091
[TBL] [Abstract][Full Text] [Related]
28. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
29. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
Gruttadauria S; Cintorino D; Piazza T; Mandala L; Doffria E; Musumeci A; Di Trapani G; Arcadipane A; Scianna G; Spada M; Verzaro R; Volpes R; Vizzini G; Palazzo U; Minervini M; Marsh JW; Marcos A; Gridelli B
Transplant Proc; 2006 May; 38(4):1106-8. PubMed ID: 16757278
[TBL] [Abstract][Full Text] [Related]
30. Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year.
Duzova A; Buyan N; Bakkaloglu M; Dalgic A; Soylemezoglu O; Besbas N; Bakkaloglu A
Transplant Proc; 2003 Dec; 35(8):2878-80. PubMed ID: 14697926
[TBL] [Abstract][Full Text] [Related]
31. Effect of immunosuppressive regimen on acute rejection and liver graft function.
Ziolkowski J; Paczek L; Niewczas M; Senatorski G; Oldakowska-Jedynak U; Wyzgal J; Foroncewicz B; Mucha K; Zegarska J; Nyckowski P; Zieniewicz K; Patkowski W; Krawczyk M; Ziarkiewicz-Wroblewska B; Gornicka B
Transplant Proc; 2003 Sep; 35(6):2281-3. PubMed ID: 14529915
[TBL] [Abstract][Full Text] [Related]
32. Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.
Ganschow R; Ericzon BG; Dhawan A; Sharif K; Martzloff ED; Rauer B; Ng J; Lopez P
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28714558
[TBL] [Abstract][Full Text] [Related]
33. Initial data on basiliximab in critically ill children undergoing heart transplantation.
Ford KA; Cale CM; Rees PG; Elliott MJ; Burch M
J Heart Lung Transplant; 2005 Sep; 24(9):1284-8. PubMed ID: 16143246
[TBL] [Abstract][Full Text] [Related]
34. Steroid-free liver transplantation in children.
Reding R; Gras J; Sokal E; Otte JB; Davies HF
Lancet; 2003 Dec; 362(9401):2068-70. PubMed ID: 14697809
[TBL] [Abstract][Full Text] [Related]
35. Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.
Gavela Martínez E; Avila Bernabeu AI; Sancho Calabuig A; Beltrán Catalán S; Escudero Quesada V; Pallardó Mateu LM
Transplant Proc; 2009; 41(6):2337-8. PubMed ID: 19715913
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK
Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
[TBL] [Abstract][Full Text] [Related]
38. Basiliximab in the therapy of acute rejection after organ transplantation.
Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
[No Abstract] [Full Text] [Related]
39. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B
Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
[No Abstract] [Full Text] [Related]
40. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT
Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
